103808-71-5

Basic information

• Product Name: Morpholine, 4-[2-(4-iodophenoxy)ethyl]-
• CAS NO: 103808-71-5
• Molecular Formula: C12H16INO2
• Molecular Weight: 333.169
• Mol File: 103808-71-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Morpholine, 4-[2-(4-iodophenoxy)ethyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Morpholine, 4-[2-(4-iodophenoxy)ethyl]-(103808-71-5)
• EPA Substance Registry System: Morpholine, 4-[2-(4-iodophenoxy)ethyl]-(103808-71-5)

Safety Data

• Hazardous Substances Data: 103808-71-5(Hazardous Substances Data)

Upstream product

• 622-40-2 2-(morpholin-4-yl)ethanol 
• 540-38-5 p-Iodophenol 
• 3647-69-6 4-(2-chloroethyl)morpholine hydrochride 

Downstream Products

• 554430-14-7 5-(tert-butyl-dimethyl-silyloxy)-2-(7-(tert-butyl-dimethyl-silyloxy)-4-{hydroxy-[4-(2-morpholin-4-yl-ethoxy)-phenyl]-methyl}-2H-chromen-3-yl)-phenol 
• 1344700-80-6 (2S)-N-(benzyloxy)-N',2-dimethyl-2-[methyl({4'-[2-(morpholin-4-yl)ethoxy]biphenyl-4-yl}carbonyl)amino]propanediamide 
• 690636-28-3 4-(2-( 4-( 4, 4, 5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)morpholine 
• 339058-36-5 (Z)-4-(2'-(4''-(1''',3'''-diphenylpent-2'''-en-2'''-yl)phenoxy)ethyl)morpholine 

Relevant articles and documents

COMPOUNDS FOR MODULATING DDAH AND ADMA LEVELS, AS WELL AS METHODS OF USING THEREOF TO TREAT DISEASE

Disclosed are compounds that can modulate DDAH and the amount of asymmetric dimethylarginine (ADMA) in a subject. Also provided are pharmaceutical compositions comprising these compounds, as well as methods of using these compositions to treat and/or prevent diseases associated with elevated or low levels of DDAH and ADMA.

Furanopyridine derivatives and methods of use

The present invention relates to furanopyridine compounds having the general Formula I: and stereoisomers, tautomers, solvates, pharmaceutically acceptable salts and derivatives, and prodrugs thereof. The invention also includes pharmaceutical composition